
Panel to decide on AstraZeneca Covid vax trials after unexplained illness in UK
New Delhi: Pharma major AstraZeneca has said it is working to expedite the review of the single event to minimise any potential impact on the trial timeline of its Covid-19 vaccine candidate.
Follow